We recognize that art is the natural expression of scientific knowledge and at Pii we are impassioned by the art and science of pharmaceutical development.Contact
Regardless of where your promising drug product is in the development process, our experienced team at Pii will seamlessly transfer the results of your efforts into our hands and quickly get to work advancing it to the next phase.
Tech transfer is often viewed as a complex process fraught with risk and the potential for something to go wrong. We believe that tech transfer done expertly is an opportunity to deliver better results to our clients and ultimately patients.
Whether you have an early concept project or looking to scale the manufacturing of your drug product, we approach each project seeking improvement: increased efficiency, lower costs, improved processes, better validation procedures, and more robust quality systems.
Experience the art and science of drug development by speaking with a project ambassador today.
“We understand the importance of commercial projects and the investment of people and time it takes to be successful. For our clients, knowing when a pharmaceutical product manufactured in our facilities will be commercially available is important, it is to us too. During tech transfer, client relationship-building is just as important to us as identifying critical process parameters. And we never forget that there is a patient who requires this therapy.”
~PJ Kim, Head of Commercial and Corporate Development
“Tech Transfer isn’t just about transferring data related to a drug product, it is about transferring an entire drug therapy supply chain—analytical methods, manufacturing processes, supplier relationships—it is comprehensive knowledge transfer and management.”
–Shawn Watson, Head of Research and Development
“Moving the development and manufacturing of a drug product to a different facility is done for many reasons, no two tech transfers are the same. Perhaps a client is adding more security to their supply chain due to the risks posed by the current pandemic or a service provider is unable to help you achieve your goals. We use a disciplined approach with robust quality systems and an understanding of the most current regulatory requirements for successful transfer of your product.”
–Dr. Sundeep Sethia, Senior Director of Research and Development
“Experience tells us that for injectable drugs, scaling batch-size alone is not often a problem. If you are having trouble, it is often associated with the scientific relationships between your formulation, process, and equipment. Those relationships are the things we examine during tech transfer, we make the adjustments, and quickly begin successful scaled-up manufacturing.”
–Dr. Brian Braxton, Senior Director of Aseptic Research and Development